|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| |||
|
a)
|
Name
|
Dr K Slaoui
| ||
|
b)
|
Position/status
|
PCA of Dr M M Slaoui (Chairman, Global Vaccines)
| ||
|
c)
|
Initial notification/
amendment
|
Initial notification
| ||
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||
|
a)
|
Name
|
GlaxoSmithKline plc
| ||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
| ||
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| |||
|
a)
|
Description of the financial instrument
|
GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
| ||
|
b)
|
Nature of the transaction
|
An increase of 1 ADS following the notional allocation of ADSs on 22 August 2016, at a price of $44.12 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.
| ||
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$44.12
|
1
| |||
|
d)
|
Aggregated information
Aggregated volume Price
|
n/a (single transaction)
| ||
|
e)
|
Date of the transaction
|
2016-08-22
| ||
|
f)
|
Place of the transaction
|
n/a
| ||